Equities

FRBN

KYG3619H1020

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
15.7 ^USD	+1.29%		+6.08%	-27.63%

2023	EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	CI
2023	Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index	CI

Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors

May 15, 2023

Forbion European Acquisition Corp. announced that it has entered into share subscription agreements to issue 5,550,408 class A shares at an issue price of $10.25 per share for gross proceeds of $56,891,682 on May 16, 2023. The transaction included participation from new investors enGene Holdings Inc., BVF Partners L.P., Omega Fund Management, LLC, Cowen Healthcare Investments, Investissement Québec, Investment Arm, Vivo Capital, LLC, Northleaf Capital Partners Ltd., CTI Life Sciences Fund III, CTI Life Sciences, and other PIPE Investors.

The company issued securities exemption from registration requirements thereof provided by Section 4(a)(2) of the Securities Act and/or Regulation D.

Latest news about FORN EUROPAR

EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	Oct. 31	CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index	23-10-31	CI
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	23-10-30	MT
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast	23-10-27	MT
Top Premarket Decliners	23-10-25	MT
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding	23-09-12	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.	23-06-05	CI
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.	23-05-16	CI
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors	23-05-15	CI
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors	23-05-15	CI
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding	23-03-23	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.	22-06-07	CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index	22-02-07	CI
Forbion European Acquisition Corp. has completed an IPO in the amount of $110 million.	21-12-09	CI
Forbion European Acquisition Corp. has filed an IPO in the amount of $100 million.	21-11-23	CI
Forbion Growth Sponsor Feac I B.V. announced that it has received $0.024998 million in funding from Forbion European Acquisition Corp.	21-08-11	CI

Chart FORN EUROPAR

Duration

Period

More charts

Company Profile

Forbion European Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination. The Company intend to focus its search on lifestyle, technology, healthcare and wellness sectors. The Company has not commenced any operations nor generated any revenue.

Sector

More about the company

Income Statement Evolution

More financial data